Moolec Science (MLEC) Current Taxes (2023 - 2024)

Moolec Science's (MLEC) quarterly Current Taxes came in at $5.9 million in Q4 2024, up 22.23% quarter-over-quarter from $4.8 million in Q2 2024.

Moolec Science (MLEC) Current Taxes (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Current Taxes across 2 years of filings, most recently posting $5.9 million for Q4 2024.

Current Taxes for Q4 2024 came in at $5.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $5.9 million (changed N/A YoY), and the FY2024 annual result was $4.8 million, up 847.93% from the prior year.
Current Taxes came in at $5.9 million for Q4 2024 at Moolec Science, up from $4.8 million in the prior quarter.
In the past five years, Current Taxes ranged from a high of $5.9 million in Q4 2024 to a low of $509034.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	723,416.35 Bn	723,416.32 Bn	-	10,460.56
2	Belite Bio	57,340.00 Bn	57,340.00 Bn	-	-
3	Quantum Biopharma	19,125.08 Bn	19,125.08 Bn	-	-
4	Legend Biotech	3,262.00 Bn	3,261.71 Bn	242.10 Mn	19.20 Mn
5	Akari Therapeutics	1,789.67 Bn	1,789.67 Bn	-	-
6	Evaxion A	1,480.39 Bn	1,480.37 Bn	-	-
7	Psyence Biomedical	241.78 Bn	241.78 Bn	-	-
8	Vertex Pharmaceuticals	113.54 Bn	106.29 Bn	2.59 Bn	-
9	Abivax	94.26 Bn	94.26 Bn	-	-
10	Moolec Science	6.98 Bn	6.98 Bn	-	-

Download Data